Engineer Your Success in Life Sciences

This is a webinar scheduled for July 9 and 12, 2022 for noon New York time (9am San Francisco | 5pm London | 6pm Paris)

Who Should Attend

1. Researchers, Professors, and Analysts aspiring to bring his/her biotech invention to the global market
2. Startup Founders, Venture Investors or Consultants looking for the next big opportunities in the Biotech sector

Why Now is the Time

1. Post-COVID investments exploding into the Life Sciences sector:

• Vision Before: 10 years to bring innovation to market

• Vision Now: Actual breakthrough is possible in 9 months!

2. Digital revolution:

• Vision Before: AI is irrelevant in biotech
• Vision Now: AI/Machine Learning — a game-changer in diagnostics and drug discovery

3. Perfect Storm of 2022: time of a big disruption, explosion in diversity and complexity. Multiplication of crises: War x Economic crisis x Logistics crisis

• Vision Before: Biotech is about pharma
• Vision Now: Biotech should be a solution to many pressing issues: Waste Management, Foodtech, Data storage, Alternative Energy, etc.

Life Sciences solutions are at the center of everything we are facing today!

More About

The talk covers a full range of issues that a global investor is looking at in a Life Sciences startup, including:

• a step-by-step guide for venture creation in Life Sciences;
• a clear framework for evaluating investment opportunities;
• case studies of most recent successful biotechnology startups.

We will address:

• Global technology trends shaping the future of Life Sciences businesses;
• The FDA and EMA models of regulation and importance of IP;
• Partnering with large pharmaceutical companies;
• Essential investment criteria and specific terms of venture deals;
• Valuation in biotechnology;
• Exit strategies: IPO / M&A deals, key investor players.

You will also have an opportunity to ask questions during an interactive Q&A session.

This is an introductory workshop to the full-fledged online education module GATE-X-LS: GLOBAL ADVANCED TECHNOLOGY ENTREPRENEURSHIP IN LIFE SCIENCES

Meet the Speaker

Anton Gopka

www.linkedin.com/in/gobbs

Anton Gopka, GATELEAD Founder and CEO, in addition to being a well-established venture capitalist and serial entrepreneur, was a dean at a leading engineering school:

Co-Founder and General Partner at ATEM Capital — NY-based Life Sciences venture firm;

Ex-Dean of the School for Technology Management and Innovation at a Global Top-100 university in Computer Sciences; Led transformation of university entrepreneurship education.

Managed one of the largest CEE biotech venture funds — a US$760M strategic partnership with Domain Associates, made 11 high-profile private investments (5 companies listed on NASDAQ, including Atea Pharmaceuticals with over 30x cash-on-cash return at IPO, 3 successful M&A deals, including Tobira Therapeutics, sold at a 19x premium to its current market capitalization to Allergan).

A member of the US National Association of Corporate Directors (NACD) and a member of the Review Committee of the US National Cancer Institute.

Executive Education — INSEAD, Harvard Business School.